Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CAMBIUM BIO LIMITED Director's Dealing 2015

Jun 3, 2015

64666_rns_2015-06-03_b17620b3-d158-44f0-83ba-f5b9b124731a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Regeneus Ltd
ABN 13 127 035 358

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director
Dr Roger Aston
Date of last notice ---------------------------------------
$N/\Lambda$
the contract of the contract of the contract of the contract of the contract of the contract of the contract of

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change 3 June 2015
No. of securities held
prior
Nil
to change
Class Full paid ordinary shares
Number acquired 51,179
Number disposed Nil
Value/Consideration \$0.1950c each
Note: If consideration is non-cash, provide details and estimated valuation
No, of securities held
after
change 51,179
Nature of change On market trade
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back

+ See chapter 19 for defined terms.

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract
Nature of interest
o f
registered
Name
holder
issued
(i f)
securities)
Date of change
No, and class
o f
securities to which
interest
related
prior to change
Note: Details are only required for a contract in relation to
which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change

Part $3 -$ +Closed period

Were the interests in the $\text{No}$
securities or contracts detailed
above traded during a + closed
period where prior written
clearance was required?
If so, was prior written clearance $N/A$
provided to allow the trade to
proceed during this period?
If prior written clearance was N/A
provided, on what date was this
provided?

+ See chapter 19 for defined terms.